POOLED SAFETY ANALYSIS OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THREE RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CLINICAL TRIALS

被引：1

作者：

Dorner, T. ^{[1
]}

Tanaka, Y. ^{[2
]}

Mosca, M. ^{[3
]}

Bruce, I. N. ^{[4
]}

Cardiel, M. ^{[5
]}

Morand, E. F. ^{[6
]}

Petri, M. A. ^{[7
]}

Silk, M. ^{[8
]}

Dickson, C. ^{[8
]}

Meszaros, G. ^{[8
]}

Issa, M. ^{[8
]}

Zhang, L. ^{[8
]}

Wallace, D. J. ^{[9
]}

机构：

[1] Charite, Med Rheumatol & Clin Immunol, Berlin, Germany

[2] Univ Occupat & Environm Hlth, First Dept Internal Med, Kitakyushu, Fukuoka, Japan

[3] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy

[4] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Manchester, Lancs, England

[5] Centro Investigac Clin Morelia, Clinical Res, Morelia, Michoacan, Mexico

[6] Monash Univ, Ctr Inflammatory Dis, Melbourne, Vic, Australia

[7] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA

[8] Eli Lilly & Co, Indianapolis, IN USA

[9] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Div Rheumatol Allergy & Immunol, Los Angeles, CA USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷

关键词：

D O I：

10.1136/annrheumdis-2022-eular.2375

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

POS0714

引用

页码：639 / 639

页数：1

共 50 条

[1] BARICITINIB IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM A PHASE 2, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Wallace, D. J.
Furie, R. A.
Tanaka, Y.
Kalunian, K. C.
Mosca, M.
Petri, M. A.
Dorner, T.
Cardiel, M. H.
Bruce, I. N.
Gomez, E.
Carmack, T.
Janes, J. M.
Linnik, M. D.
Silk, M.
Hoffman, R.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 59 - 59
[2] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Wallace, Daniel J.
Furie, Richard A.
Tanaka, Yoshiya
Kalunian, Kenneth C.
Mosca, Marta
Petri, Michelle A.
Doerner, Thomas
Cardiel, Mario H.
Bruce, Ian N.
Gomez, Elisa
Carmack, Tara
DeLozier, Amy M.
Janes, Jonathan M.
Linnik, Matthew D.
de Bono, Stephanie
Silk, Maria E.
Hoffman, Robert W.
LANCET, 2018, 392 (10143): : 222 - 231
[3] Baricitinib in Patients with Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Wallace, Daniel J.
Furie, Richard
Tanaka, Yoshiya
Kalunian, Kenneth C.
Mosca, Marta
Petri, Michelle
Dorner, Thomas
Cardiel, Mario H.
Bruce, Ian N.
Gomez, Elisa
DeLozier, Amy M.
Janes, Jonathan
Linnik, Matthew D.
de Bono, Stephanie
Silk, Maria E.
Hoffman, Robert W.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[4] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM TWO RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 3 STUDIES
Morand, E. F.
Tanaka, Y.
Furie, R.
Vital, E.
van Vollenhoven, R.
Kalunian, K.
Mosca, M.
Doerner, T.
Wallace, D. J.
Silk, M.
Dickson, C.
De la Torre, I.
Meszaros, G.
Jia, B.
Crowe, B.
Petri, M. A.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 327 - 328
[5] Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
Sun, Fangfang
Wang, Hui Jing
Liu, Zhe
Geng, Shikai
Wang, Haiting
Wang, Xiaodong
Li, Ting
Morel, Laurence
Wan, Weiguo
Lu, Liangjing
Teng, Xiangyu
Ye, Shuang
LANCET RHEUMATOLOGY, 2020, 2 (04): : E210 - E216
[6] Dehydroepiandrosterone in systemic lupus erythematosus - Results of a double-blind, placebo-controlled, randomized clinical trial
vanVollenhoven, RF
Engleman, EG
McGuire, JL
ARTHRITIS AND RHEUMATISM, 1995, 38 (12): : 1826 - 1831
[7] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
Petri, Michelle
Bruce, Ian N.
Doerner, Thomas
Tanaka, Yoshiya
Morand, Eric F.
Kalunian, Kenneth C.
Cardiel, Mario H.
Silk, Maria E.
Dickson, Christina L.
Meszaros, Gabriella
Zhang, Lu
Jia, Bochao
Zhao, Youna
McVeigh, Conor J.
Mosca, Marta
LANCET, 2023, 401 (10381): : 1011 - 1019
[8] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
Morand, Eric F.
Vital, Edward M.
Petri, Michelle
van Vollenhoven, Ronald
Wallace, Daniel J.
Mosca, Marta
Furie, Richard A.
Silk, Maria E.
Dickson, Christina L.
Meszaros, Gabriella
Jia, Bochao
Crowe, Brenda
Torre, Inmaculada de la
Doerner, Thomas
LANCET, 2023, 401 (10381): : 1001 - 1010
[9] Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial
Doerner, Thomas
van Vollenhoven, Ronald F.
Doria, Andrea
Jia, Bochao
Terres, Jorge A. Ross
Silk, Maria E.
de Bono, Stephanie
Fischer, Peter
Wallace, Daniel J.
ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
[10] A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
van Vollenhoven, RF
Park, JL
Genovese, MC
West, JP
McGuire, JL
LUPUS, 1999, 8 (03) : 181 - 187

← 1 2 3 4 5 →